Cardiovascular Disease Found to Raise ESRD Risk
Not only do kidney disease patients have higher rates of cardiovascular events, cardiovascular disease events may increase the risk of end-stage renal disease in the general population.
Not only do kidney disease patients have higher rates of cardiovascular events, cardiovascular disease events may increase the risk of end-stage renal disease in the general population.
A study found that patients with more advanced-stage upper tract urothelial carcinoma had a higher prevalence of lymph node metastasis.
Clinicians should weigh the benefits and risks of renin-angiotensin-aldosterone-system inhibitors and diuretics, according to investigators.
A large study found similar graft survival rates between deceased donor kidneys with and without acute kidney injury.
In a randomized trial of men with PSA relapse following radical prostatectomy, 5-year freedom from bicalutamide treatment failure was significantly greater with salvage radiation prior to salvage hormone therapy than salvage hormone therapy alone.
In a study, high PTRF expression indicated clinically aggressive UTUC in both Taiwanese and Caucasian patients.
Phase 3 study data show a majority of ESA-treated and ESA-naïve hemodialysis patients taking roxadustat maintained a target hemoglobin range of 10.0 to 12.0 g/dL at 18 to 24 weeks.
Representatives of Congress are introducing legislation for kidney transplant recipients to obtain coverage of immunosuppressive medications for the lifetime of their transplanted kidney.
According to the American College of Physicians’ guideline, clinicians should prescribe testosterone treatment only to men with sexual dysfunction symptoms.
In a study, emergency department patients who experienced serum potassium normalization within 3 to 8 hours had half the death risk of those with persistent hyperkalemia.